Clinical Trial: A Trial of Pyridoxamine to Lower Urine Oxalate in Subjects With Stone Disease or Hyperoxaluria
Study Status: Withdrawn
Recruit Status: Withdrawn
Study Type: Interventional
Official Title: Effects of Pyridoxamine on Oxalate Excretion in Stone Disease and Hyperoxaluria
Brief Summary: To determine whether pyridoxamine can decrease oxalate excretion in subjects who have normal oxalate excretion (but who have had kidney stones), and in subjects who have primary hyperoxaluria.
Detailed Summary:
Sponsor: University of Kansas Medical Center
Current Primary Outcome: Urinary Excretion of Oxalate at Highest Dose [ Time Frame: 4 Weeks ]
Original Primary Outcome: Same as current
Current Secondary Outcome: Change in Urinary Supersaturation [ Time Frame: 4 Weeks ]
Original Secondary Outcome: Same as current
Information By: University of Kansas Medical Center
Dates:
Date Received: June 20, 2007
Date Started: January 2007
Date Completion:
Last Updated: January 3, 2017
Last Verified: January 2017